logo
Potsdam Food Co-op will build new store; general manager named

Potsdam Food Co-op will build new store; general manager named

Yahoo14-06-2025
Jun. 14—POTSDAM — The Potsdam Food Co-op will use their 2019 2019 Downtown Revitalization Initiative award to build a new store. The co-op board also named Jessie LaRose as the store's new general manager.
The $1.6 million DRI award will construct a new 5,340 square foot grocery store at 24 Elm St. to accommodate a larger store, office space, and parking. About 3,000 square feet will be allocated for retail. The new store will replace the existing co-op structure.
The store design was completed by Aubertine & Currier, an architectural and engineering firm based in Watertown.
The DRI funds will pay for design, engineering, and environmental work.
Roughly $3.7 million in additional resources will need to be secured from other sources including grants and loans for building construction, fixtures, equipment, inventory, and project management.
The new co-op building will be fully accessible and fully electric in support of New York State's renewable energy and decarbonization goals, a news release from the co-op board says.
The co-op board unanimously voted LaRose from acting general manager to general manager. She has nearly 17 years of experience at the co-op. She was named acting general manager in February 2024.
"I've lived in and loved Potsdam for more than half of my life and the Co-op has been like a second home for the majority of that time," LaRose said in a news release. "It's a privilege and an honor to be in this role, especially as we move forward with our long-awaited expansion." She added, "I'm grateful for the Board of Directors for their support and trust in me and the opportunity to lead our food co-op. I look forward to continuing to work with the board and the staff to achieve the goals we have set together, and grow this vital community organization."
"I am so excited to see all of the progress we have made on our expansion efforts, and even more excited for the new co-op that will result from all of this hard work," LaRose said in the release. "It is very rewarding work. We are incredibly grateful for everything that has allowed us to get to this point in the project. The DRI is a real blessing, and we are thrilled to be under contract with New York State."
"Jessie has been instrumental in shepherding the co-op through very challenging times as our acting general manager," co-op board president Andre Comandon said in the release. "We have been excited to see her and the staff's hard work pay off with an improving financial outlook and concrete steps toward the co-op expansion."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Is Wall Street Bullish or Bearish on Darden Restaurants Stock?
Is Wall Street Bullish or Bearish on Darden Restaurants Stock?

Yahoo

time7 hours ago

  • Yahoo

Is Wall Street Bullish or Bearish on Darden Restaurants Stock?

Orlando, Florida-based Darden Restaurants, Inc. (DRI) owns and operates full-service restaurants. With a market cap of $24.2 billion, the company owns and operates a variety of seafood and Italian restaurants under a multitude of brand names, serving customers in the U.S. and Canada. Shares of this leading full-service restaurant operator have considerably outperformed the broader market over the past year. DRI has gained 43.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 16.4%. In 2025, DRI stock is up 11.1%, surpassing the SPX's 9.7% rise on a YTD basis. More News from Barchart Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Powell, Trump Talks and Other Can't Miss Items this Week Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Zooming in further, DRI's outperformance is also apparent compared to the AdvisorShares Restaurant ETF (EATZ). The exchange-traded fund has gained about 13% over the past year. Moreover, DRI's low double-digit returns on a YTD basis outshine the ETF's 1.9% gains over the same time frame. On Jun. 20, DRI shares closed up more than 1% after reporting its Q4 results. Its adjusted EPS of $2.98 surpassed Wall Street expectations of $2.96. The company's revenue was $3.3 billion, matching Wall Street forecasts. DRI expects full-year adjusted EPS to be $10.50 to $10.70. For fiscal 2026, ending in May 2026, analysts expect DRI's EPS to grow 11.3% to $10.63 on a diluted basis. The company's earnings surprise history is disappointing. It missed the consensus estimate in three of the last four quarters while beating the forecast on another occasion. Among the 28 analysts covering DRI stock, the consensus is a 'Moderate Buy.' That's based on 16 'Strong Buy' ratings, two 'Moderate Buys,' and 10 'Holds.' This configuration is less bearish than three months ago, with one analyst suggesting a 'Moderate Sell.' On Jul. 31, Barclays PLC (BCS) analyst Jeff Bernstein maintained a 'Buy' rating on DRI and set a price target of $255, the Street-high price target, implying a potential upside of 23% from current levels. The mean price target of $234.75 represents a 13.2% premium to DRI's current price levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio

Customer sparks outrage with photo of bizarre discovery in shelf at Goodwill: 'This is getting ridiculous'
Customer sparks outrage with photo of bizarre discovery in shelf at Goodwill: 'This is getting ridiculous'

Yahoo

time5 days ago

  • Yahoo

Customer sparks outrage with photo of bizarre discovery in shelf at Goodwill: 'This is getting ridiculous'

A shocking post to the subreddit r/ThriftGrift revealed out-of-place high prices for knick-knacks at a Goodwill. "This is getting ridiculous," the OP wrote, along with images of somewhat shabby trinkets being sold for exceptionally high prices. It's no secret that thrifting has blown up in popularity in recent years. Younger generations have found thrift stores to be an oasis of cheap, high-quality items that support a greener, cleaner future. Amid the heightened popularity of thrifting, the Trump administration's tariffs on imported goods have shifted even more attention to secondhand shopping. Price hikes on imported clothing from global retailers are leading consumers to turn toward more affordable options. Business Insider reported that ThredUp, a large second-hand clothing retailer, "predicts it will reach $73 billion by 2028 in the US and $350 billion globally, up from $197 billion in 2023." This is overwhelmingly good news for thrift stores, which have always been competing with cheap fast-fashion clothing that uplifts micro-trends that go out of style quickly and are made with low-quality materials that break swiftly. As a result, fast fashion is responsible for 10% of global planet-harming pollution and takes up an expansive proportion of landfills, which both pollute the air, water, and soil. Thrift stores, which usually resell clothes that have long lifespans, ensure that one does not have to replenish their wardrobe constantly. Meanwhile, they are substantially making a difference to the environment. This Goodwill, in particular, may have responded by capitalizing on consumers' newfound reliance on secondhand items. Despite the prices being an outlier from typical thrift stores, they still sparked anger among shoppers. The appeal of thrift stores has always been cheap goods that support the circular economy. Now, these prices reflect otherwise. "Thankfully, the Goodwill stores near me haven't gotten this out of control with their hard goods yet," wrote one commenter. Another responded in complete disbelief at the prices. "Who's buying this stuff?" they asked. What's your primary motivation in shopping at thrift stores? Cheaper clothes Trendier items Reduced environmental impact I don't thrift Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals

Yahoo

time6 days ago

  • Yahoo

Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the . The company sees its Buy rating reiterated following promising results from its clinical trials, including the VERITAC-2 trial. A close-up of a pharmacist in a gleaming white labcoat holding a vial of biopharmaceuticals. Headquartered in California, Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for women's cancers. Its lead product candidate, palazestrant (OP-1250), is an estrogen receptor (ER) antagonist and degrader being evaluated in clinical trials for breast cancer. The company also has another drug candidate, OP-3136, a KAT6 inhibitor, in Phase 1 clinical trials. In its Q1 earnings report, released on May 13, 2025, the company announced that the OPERA-02 trial for palazestrant and ribociclib in breast cancer is on track for initiation in 2025. The OPERA-01 monotherapy trial also continues, with results expected in 2026. Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) has further promising results in clinical data for OP-3136 in multiple cancer types. Additionally, the company's trials on VERITAC-2 showed that the drug is more effective for metastatic breast cancer with ESR1 mutations, as it improves survival with a good safety profile. Following these developments, H.C. Wainwright reiterated the Buy rating on the stock while maintaining the price target of $28.00. Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is showing a potential short-term rebound, gaining 7.19% this week despite a decline of 67.38% over the past year, attracting the interest of short-term investors. While we acknowledge the potential of OLMA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store